Literature DB >> 28612332

Cocaine-Levamisole-Induced Vasculitis/Vasculopathy Syndrome.

Javier Marquez1, Lina Aguirre2, Carolina Muñoz3, Andres Echeverri3, Mauricio Restrepo3,4, Luis F Pinto3.   

Abstract

PURPOSE OF REVIEW: To understand the clinical spectrum of cocaine-levamisole-induced vasculitis. Worldwide recreational drug consumption is high among the adult population from various social strata. The use of cocaine with levamisole, a frequently added antiparasitic diluent, favors the manifestations of vasculitic lesions, especially in the skin. RECENT
FINDINGS: New insights into immunological mechanisms involved in the pathogenesis of the disease. There are still many unknown aspects in the pathogenesis of this disease, such as the immune system interaction with p-ANCAs and the release of inflammatory NETs (neutrophil extracellular traps), which are the origin of auto-antigens and tissue damage, manifesting as vasculitic purpura on the skin. The clinical presentation constitutes a challenge for the clinician to be able to distinguish it from small-vessel vasculitides. This paper intends to improve the understanding of this condition, exhibiting the broad clinical spectrum of local and systemic manifestations of cocaine-levamisole-induced vasculitis, to facilitate a timely diagnosis, in order to take corrective measures and avoid sequelae, along with tissue damage and the consequent deformities and permanent scars.

Entities:  

Keywords:  Anti-neutrophil cytoplasmic antibody-associated vasculitis; Cocaine-related disorders; Cutaneous; Leukocytoclastic; Levamisole; Vasculitis

Mesh:

Substances:

Year:  2017        PMID: 28612332     DOI: 10.1007/s11926-017-0653-9

Source DB:  PubMed          Journal:  Curr Rheumatol Rep        ISSN: 1523-3774            Impact factor:   4.592


  31 in total

1.  A novel cutaneous vasculitis syndrome induced by levamisole-contaminated cocaine.

Authors:  Rachel L Gross; Jason Brucker; Asena Bahce-Altuntas; Maria A Abadi; Jules Lipoff; David Kotlyar; Peter Barland; Chaim Putterman
Journal:  Clin Rheumatol       Date:  2011-06-25       Impact factor: 2.980

Review 2.  Mucocutaneous manifestations of illicit drug use.

Authors:  Kachiu C Lee; Barry Ladizinski
Journal:  Int J Dermatol       Date:  2014-04-02       Impact factor: 2.736

3.  Five consecutive cases of a cutaneous vasculopathy in users of levamisole-adulterated cocaine.

Authors:  Korey Ullrich; Robert Koval; Erin Koval; Srinivas Bapoje; Joel M Hirsh
Journal:  J Clin Rheumatol       Date:  2011-06       Impact factor: 3.517

4.  Syndrome of cocaine-levamisole-induced cutaneous vasculitis and immune-mediated leukopenia.

Authors:  Samuel H Poon; Crisostomo R Baliog; Ralph N Sams; Leslie Robinson-Bostom; Gladys H Telang; Anthony M Reginato
Journal:  Semin Arthritis Rheum       Date:  2011-08-24       Impact factor: 5.532

5.  Clinicopathologic features of agranulocytosis in the setting of levamisole-tainted cocaine.

Authors:  David R Czuchlewski; Monica Brackney; Christina Ewers; Jonaki Manna; M Houman Fekrazad; Afton Martinez; Kurt B Nolte; Brian Hjelle; Ian Rabinowitz; Brian R Curtis; Janice G McFarland; Joan Baumbach; Kathryn Foucar
Journal:  Am J Clin Pathol       Date:  2010-03       Impact factor: 2.493

6.  Plasmapheresis and steroid treatment of levamisole-induced vasculopathy and associated skin necrosis in crack/cocaine users.

Authors:  Katerina Pavenski; Hilde Vandenberghe; Henry Jakubovic; David N Adam; Bernadette Garvey; Catherine J Streutker
Journal:  J Cutan Med Surg       Date:  2013 Mar-Apr       Impact factor: 2.092

Review 7.  Cocaine-levamisole thrombotic vasculopathy.

Authors:  Irene A Dy; Peter H Wiernik
Journal:  Semin Thromb Hemost       Date:  2012-10-06       Impact factor: 4.180

Review 8.  Pathologic manifestations of levamisole-adulterated cocaine exposure.

Authors:  Amber L Nolan; Kuang-Yu Jen
Journal:  Diagn Pathol       Date:  2015-05-06       Impact factor: 2.644

9.  Levamisole-induced leukocytoclastic vasculitis and neutropenia in a patient with cocaine use: an extensive case with necrosis of skin, soft tissue, and cartilage.

Authors:  Natasha Purai Arora; Tania Jain; Ravinder Bhanot; Suganthini Krishnan Natesan
Journal:  Addict Sci Clin Pract       Date:  2012-09-24

Review 10.  Is Levamisole-Induced Vasculitis a Relegated Diagnostic Possibility? A Case Report and Review of Literature.

Authors:  Soumya Patnaik; Percy Balderia; Lisa Vanchhawng; Peyman Markazi; Jedrzej Wykretowicz; Sarah Perloff
Journal:  Am J Case Rep       Date:  2015-09-25
View more
  5 in total

Review 1.  ANCA-Associated Vasculitides and Hematologic Malignancies: Lessons from the Past and Future Perspectives.

Authors:  Marco Folci; Giacomo Ramponi; Dana Shiffer; Aurora Zumbo; Michele Agosti; Enrico Brunetta
Journal:  J Immunol Res       Date:  2019-05-06       Impact factor: 4.818

Review 2.  Drug-induced anti-neutrophil cytoplasmic antibody-associated vasculitis.

Authors:  Cheng-Hua Weng; Zhi-Chun Liu
Journal:  Chin Med J (Engl)       Date:  2019-12-05       Impact factor: 2.628

3.  Cocaine/Levamisole-Induced, Skin-Limited ANCA-Associated Vasculitis with Pyoderma Gangrenosum-like Presentation.

Authors:  Mirjana Urosevic-Maiwald; Jan-Hendrik B Hardenberg; Jürg Hafner; Marie-Charlotte Brüggen
Journal:  Dermatopathology (Basel)       Date:  2022-06-29

4.  Leukocytoclastic Vasculitis Induced by Cocaine Adulterated with Levamisole.

Authors:  Alberto Barbotti; Alina Cristiana Gheorghiu; Tanja Fusi-Schmidhauser; Lorenzo Grazioli-Gauthier
Journal:  Eur J Case Rep Intern Med       Date:  2022-07-25

5.  Cocaine-Induced Midline Destructive Lesions: A Real Challenge in Oral Rehabilitation.

Authors:  Andrea Rampi; Alessandro Vinciguerra; Stefano Bondi; Nicoletta Stella Policaro; Giorgio Gastaldi
Journal:  Int J Environ Res Public Health       Date:  2021-03-20       Impact factor: 3.390

  5 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.